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SUMMARY. Although the pathogenesis of cervical inlet patch (CIP) is not fully understood, most authors
consider it as a congenital abnormality, whereas others surmise it to be related to gastroesophageal reflux disease
(GERD). We aimed to evaluate esophageal function and the prevalence of GERD and Barrett’s esophagus in
patients with CIP. GERD is defined by the presence of erosive esophagitis or an abnormal pH monitoring.
Seventy-one consecutive patients with endoscopic and histological evidence of CIP were prospectively evaluated.
Esophageal symptom analysis, 24-hour simultaneous biliary reflux and double-channel pH-monitoring, and esopha-
geal manometry were carried out in 65/71 (92%) patients and in 25 matched controls. Six patients were not suitable
for testing and were, therefore, excluded. The histological evaluation of the heterotopic islands showed cardia
and/or oxyntic mucosa in 64/65 (98%) patients and specialized intestinal metaplasia (SIM) in one patient (2%). The
cardia and/or oxyntic mucosa was accompanied by focally appearing pancreatic acinar metaplasia and pancreatic
ductal metaplasia in 7/64 (11%) and in 1/64 (2%), superficial mucous glands in 6/64 (9%), and SIM in 2/64 (3%)
cases. In total, SIM was present in three patients (5%), and one of them had low-grade dysplasia. At the
gastroesophageal junction, 28 (43%) patients had columnar metaplasia, including nine (14%) patients with SIM.
Erosive esophagitis was present in 37 (57%) cases. Thirty-two patients (49%) had abnormal acid reflux in the distal
and 25 (38%) in the proximal esophagus. Abnormal biliary reflux was present in 25 (38%) cases. On the basis of
endoscopic and pH studies, GERD was established in 44/65 (68%) patients. Typical reflux symptoms were common
(33/65, 51%). The combined 24-hour biliary and double-channel pH-monitoring detected significantly more sig-
nificant acidic reflux at both measurement points and significantly longer bile exposure time in the distal esophagus
in patients with CIP. Acid secretion in the CIP was detected in three (5%) cases. Esophageal manometry revealed
decreased LES pressure and prolonged relaxation with decreased peristaltic wave amplitude, and an increased
number of simultaneous contractions in the esophageal body. The detailed evaluation of the esophageal morphology
and function in subjects with CIP showed a high prevalence of GERD and Barrett’s esophagus. Further studies are
needed to evaluate whether combined acidic and biliary reflux is able to promote similar histomorphological
changes in the CIP, as it is shown distally in patients with Barrett’s esophagus.
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INTRODUCTION
A cervical inlet patch (CIP) is a heterotopic columnar
mucosal island in the cervical esophagus. Currently,
most authors consider it a congenital abnormality;
however, others suspect that it has a common patho-
genesis with Barrett’s esophagus and it is related to
gastroesophageal reflux disease (GERD).1 Recently,
Meining and Bajbouj published a new theory accord-
ing to which a CIP may develop from mucus gland
cysts of the cervical esophagus after eruption.2 The
detection of CIP is difficult and highly dependent on
the endoscopist.3 Consequently, its prevalence varies
between 0.1 and 10% in the literature.4–6 The clinical
significance of CIP is still largely unknown because
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most studies evaluated a small series of patients and
the available data are almost exclusively restricted to
the endoscopic and histological description of this
entity.
Therefore, in the present study, we set out to
evaluate the esophageal function in patients with a
CIP and to investigate its relationship to GERD and
Barrett’s esophagus.
PATIENTS AND METHODS
In January 2006, we launched a prospective study to
evaluate the esophageal function in patients with
CIP. Until June 2009, 11,700 consecutive patients
with various gastrointestinal symptoms underwent
upper gastrointestinal endoscopy at the endoscopy
unit of our institution. Endoscopists were aware of
the study but were not instructed to pay a special
attention in looking for CIP. Seventy-one (0.6%) of
these patients (41 males, 30 females, mean age: 49
[23–77] years, mean body mass index [BMI] 26.1
[17.0–46.2]) had histologically confirmed endoscopic
evidence of CIP. In 65 of these patients, esophageal
function tests (esophageal manometry and 24-hour
double-channel pH-metry combined with biliary
reflux monitoring) and esophageal symptom screen-
ing were carried out. Six patients (four males, two
females) were not suitable for the evaluation of
esophageal function and were, therefore, excluded
from further studies: two patients with Los Angeles
grade D (LA-D) esophagitis had severe peptic eso-
phageal stricture, one with LA-A esophagitis had a
large Zenker’s diverticulum, one had previous corro-
sive injury (lye ingestion in childhood) and subse-
quent multiple stricture formation, one had advanced
lung cancer, and one had advanced pancreatic
cancer. These patients had cardia/oxyntic type meta-
plasia in the CIP without other metaplasia or dyspla-
sia. Five had single and one double patch. The size of
the patch was <10 mm in three, 10–20 mm in two,
and >20 mm in one patient.
An age-, sex-, and BMI-matched group of 25 sub-
jects without CIP and without any other esophageal
disease or symptom were evaluated as controls (males:
14, females: 11, mean age: 48 [25–71] years, BMI: 25.8
[18.9–36.0]). During the course of esophageal function
testing, all conflicting drugs were stopped appropri-
ately. Proton pump inhibitors were stopped 7 days
before testing, whereas other drugs affecting gas-
trointestinal motility, acid secretion, or visceral sensi-
tivity were suspended 72 hours before evaluation. The
study protocol was approved by the Medical Ethics
Committee of the University of Szeged.
Esophageal symptom analysis
Patients were asked to complete a standardized
questionnaire7 regarding their symptoms related to
GERD, such as heartburn, chest pain, gastroesoph-
ageal acid regurgitation, dysphagia, globus sensation,
coughing, and wheezing. Smoking habits and alcohol
and coffee consumption were also recorded.
Upper gastrointestinal endoscopy and
histological evaluation
The presence and the severity of esophagitis
were assessed by upper gastrointestinal endoscopy
(Olympus Q130, Q160, GIF-FQ 260Z) on the basis of
the LA classification.8 The histological evaluation
consisted of standard hematoxylin-eosin, Giemsa,
and periodic acid Schiff-Alcian blue (pH = 2.5) stain-
ings. The counterparts of columnar metaplasia were
divided into cardiac, fundus (oxyntic), oxyntocar-
diac, and specialized intestinal ones. Furthermore,
other associated columnar mucosa was also noted as
pancreatic acinar metaplasia (PAM) and pancreatic
ductal cell metaplasia (PDM), together with superfi-
cial mucous glands within the metaplastic area. His-
tologically, superficial mucous glands are located
beneath the foveolar epithelium. Although they may
resemble to cardiac glands, their cytoplasm contains
more translucent, mainly neutral mucin reminiscent
of ulcer-associated cell lineage, or of ‘pseudopyloric’
metaplasia. Moreover, superficial mucous glands are
arranged in a typical back-to-back architecture in the
lamina propria, and they never reach the luminal
surface. If dysplasia was suspected further, immuno-
histochemical investigation was performed using p53
(clone Do7, Labvision Corporation, Fremont, CA,
USA) and Ki67 (clone B56, Histopathology Ltd.,
Budapest, Hungary) antibodies to minimize the inter-
observer variation.
24-hour double-channel intraesophageal
pH-monitoring with simultaneous biliary
reflux monitoring
The 24-hour intraesophageal pH-monitoring studies
was carried out on an inpatient basis using the clas-
sical DeMeester criteria.9,10 Both biliary reflux values
and proximal pH results were considered abnormal in
accordance with Cool’s criteria.11 After an overnight
fasting period, a double-channel, nasoesophageal,
antimony pH-probe (Synectics Medical, Stockholm,
Sweden) was positioned. The pH sensors were located
at 5 and 20 cm above the LES and were connected to
a portable data logger (Digitrapper pH, Synectics
Medical). A computer-assisted data analysis was
carried out with the Polygram for Windows 98 soft-
ware supplied by Synectics Medical. The following
parameters such as the number of pH < 4 episodes,
the percentage of the time below pH 4, the number of
pH < 4 episodes longer than 5 minutes, and the
longest pH < 4 episode were recorded during the full
length of the study and were evaluated separately in
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the upright, supine, and postprandial (120 minutes)
periods. The DeMeester score was also calculated.
For the biliary reflux monitoring, a fiber-optic probe
was positioned 5 cm above the LES and was con-
nected to a portable data logger (Bilitec 2000, Synec-
tics Medical). Optical density (OD) was measured at
540 nm wavelength. Parameters such as the number
of OD > 0.14 episodes, the percentage of the time
above OD 0.14, the number of OD > 0.14 episodes
longer than 5 minutes, and the longest OD > 0.14
episode were recorded during the full length of the
study and were evaluated separately in the upright,
supine, and postprandial (120 minutes) periods.
During pH and biliary reflux monitoring, patients
were on a standard diet. To rule out food-induced
artifacts during biliary reflux monitoring, all reflux
episodes that started during meals were excluded, and
foods that may cause color interference were not
allowed.
Esophageal manometry
Esophageal motility was studied by standard water-
perfused stationary manometry (Polygraph HR, Syn-
ectics Medical) with computer-assisted analysis of
the tracings (Polygram 5.06C2, Synectics Medical)
according to our previously published protocol.
Briefly, after an overnight fasting period, a nasoe-
sophageal probe was introduced. The station pull-
through technique was applied, and measurements
were made at the levels of the LES, the esophageal
body, the upper esophageal sphincter, and the
pharynx on the basis of Castell’s criteria.12,13
Statistical analysis
For statistical analysis, the GraphPad Prism 4.0 soft-
ware (GraphPad, La Jolla, CA, USA) was used.
Group means were compared by Student’s unpaired
t-test, with the Welch’s correction if the variances
were different. The level of significance was set at
P < 0.05.
RESULTS
The morphological evaluation of the heterotopic
mucosal islands showed that 47 (72%) patients had
single, 14 (22%) had double, and 4 (6%) had triple
mucosal patches. The size of the patches varied
between 2 mm and 30 mm: <10 mm: 22/65 (31%),
10–20 mm: 37/65 (57%), >20 mm: 6/65 (9%). The
dominant histological structure was cardia and/or
oxyntic type mucosa (COM) in 64/65 (98%) patients,
whereas one (2%) patient had specialized intestinal
metaplasia (SIM). This latter patient had long-
segment Barrett’s esophagus as well in the distal part
of the esophagus. In patients with COM-type patches,
the dominant histological pattern was accompanied
by focally appearing PAM and PDM metaplasia in
7/64 (11%) and in 1/64 (2%), superficial mucous glands
in 6/64 (9%), and SIM in 2/64 (3%) cases. In total, SIM
was present in 3/65 patients (5%), and one of them had
low-grade dysplasia. High-grade dysplasia or invasive
adenocarcinoma was not observed in the heterotopic
mucosal patches of our patients.
Upper gastrointestinal endoscopy showed erosive
esophagitis in the distal esophagus in 37/65 (57%)
cases (LA-A: 14/65 [21%], LA-B: 12/65 [18%], LA-C:
8/65 [12%], LA-D: 3/65 [5%]), whereas the mucosa
was macroscopically intact in 28/65 (43%) subjects.
Axial hiatal hernia was seen in 29/65 (45%) patients,
with a size range of 2–7 cm.
In the distal esophagus, 28/65 (43%) patients had
columnar metaplasia. Sixteen of them (16/65, 25%)
had COM alone, and 4/65 (6%) had SIM alone. The
remaining 8/65 (12%) patients had predominantly
COM in the distal esophagus with focally present
SIM in five, PAM in four, superficial mucous glands
in three cases, and PDM in one patient. Low-grade
dysplasia was observed in three of the nine (33%)
patients with SIM and in none of the patients without
SIM. Neither high-grade dysplasia nor invasive
adenocarcinoma was observed in the metaplastic
mucosa of the distal esophagus. The mean length of
columnar metaplasia in the distal esophagus was 1.0
(0.5–1.5) cm in patients with COM and 5.5 (0.5–17.0)
cm in patients with SIM.
Clinical symptom analysis was carried out in 65
patients who underwent the esophageal function tests.
Twenty-five of them (25/65, 38%) were either com-
pletely free of the evaluated esophageal and extra-
esophageal symptoms (10/65, 15%) or had such symp-
toms less than once a week (15/65, 23%). Forty
patients (40/65, 62%) had symptoms occurring at least
once a week. These were predominantly heartburn
and/or acid regurgitation reported by 33/65 (51%)
patients, whereas other symptoms such as chest
pain, chronic cough, asthmatic wheezing, dysphagia,
or globus sensation were less frequently observed
(Table 1). The number of abstinent patients (smoking,
and alcohol and coffee consumption) was 47/65 (72%),
37/65 (57%), and 29/65 (45%), respectively.
Table 1 Prevalence of esophageal and extraesophageal symptoms
occurring at least once a week in patients with cervical inlet patch
Symptom Prevalence
Heartburn 22/65 (31%)
Acid regurgitation 22/65 (31%)
Heartburn or acid regurgitation 33/65 (51%)
Chest pain 16/65 (25%)
Cough 9/65 (14%)
Asthma/wheezing 6/65 (9%)
Dysphagia 11/65 (17%)
Globus sensation 4/54 (6%)
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The manometry of the LES showed significantly
decreased pressure, length, and abdominal length in
patients with CIP, whereas the relaxation time was
significantly longer compared with controls. In the
esophageal body, the amplitudes of peristaltic waves
were decreased, and the number of simultaneous con-
tractions was increased compared with controls. The
duration, the propagation velocity of the esophageal
body contractions, and the studied parameters of
the upper esophageal sphincter region were similar
(Table 2).
The 24-hour combined biliary reflux and double-
channel pH-monitoring revealed that patients with
CIP had significantly more distal and proximal acidic
reflux than controls. During biliary reflux monitor-
ing, the number of reflux episodes was similar, but
patients with CIP had significantly longer bile expo-
sure time in the esophagus (Table 3). According to
the internationally accepted normal values, abnormal
acidic reflux was observed in the distal esophagus in
32/65 (49%) patients. Abnormal proximal acidic
reflux was detected in 25/65 (38%) cases. Abnormal
biliary reflux was found in 25/65 (38%) cases. Com-
bined abnormal biliary and acidic reflux was
observed in 16/65 (25%) patients. On the other hand,
14/65 (21%) patients had no proximal reflux at all.
Ten of them had normal distal pH profiles as well,
with the highest DeMeester score of 6.5. Further-
more, 9 of these 10 patients had normal parameters
on biliary reflux monitoring as well.
When combining the results of endoscopy and
pH-monitoring, abnormal acid exposure was found
in the distal esophagus in 6/28 (21%) patients without
esophagitis, whereas it was 7/14 (50%), 8/12 (75%),
8/8 (100%), and 3/3 (100%) in patients with LA-A,
LA-B, LA-C, and LA-D esophagitis, respectively.
Eleven of the 33 patients (33%) with normal
pH-monitoring had erosions in the distal esopha-
gus: 7/11 LA-A, 4/11 LA-B. However, 44/65 (68%)
patients had GERD, based on the abnormal results
of endoscopy or pH-monitoring.
Temporary acid secretion of the heterotopic
mucosa was proved only in 3/65 (5%) cases.
Gastrointestinal diseases other than GERD and
Barrett’s esophagus were infrequent in our patients
with CIP. Helicobacter pylori-positive gastritis was
found in 11/65 (15%); none of them had colonization
of the bacterium in the heterotopic mucosa. We also
diagnosed celiac disease in two patients and Crohn’s
disease in one.
DISCUSSION
Although, recently, a number of papers were pub-
lished on the clinical significance of CIPs, a detailed
prospective analysis of the esophageal function of
such patients has not been carried out yet. Moreover,
most studies evaluated a relatively low number of
patients. To our knowledge, our study is the largest in
Table 2 Manometric assessment of the esophageal function in patients with cervical inlet patch (mean  SEM)
Patient group CIP (n = 65) Controls (n = 25) P
LES
Pressure (mmHg)† 14.1 0.9 26.8 1.7 <0.001
Relaxation time (second) 10.9 0.3 8.7 0.3 <0.001
Length (cm) 3.2 0.1 4.8 0.2 <0.001
Abdominal length (cm) 1.4 0.2 3.3 0.2 <0.001
DS WS DS WS DS WS
EB peristaltic wave
Amplitude at
3 cm 56 5 84 5 83 8 116 6 <0.01 <0.001
8 cm 46 3 78 5 68 8 101 6 <0.02 <0.01
13 cm 34 3 50 5 51 5 69 6 <0.01 <0.02
18 cm 32 4 44 4 50 9 57 7 =0.06 =0.07
Above the LES (mmHg)
Duration at
3 cm 3.6 0.1 3.6 0.1 3.7 0.2 3.8 0.2 ns ns
8 cm 3.2 0.1 3.5 0.1 3.4 0.2 3.5 0.2 ns ns
13 cm 3.0 0.1 3.0 0.1 3.3 0.2 3.1 0.1 ns ns
18 cm 2.7 0.1 2.6 0.1 2.4 0.1 2.4 0.1 ns ns
Above the LES (second)
Propagation velocity (cm/s) 3.6 0.1 3.2 0.2 3.9 0.2 3.3 0.1 ns ns
Simultaneous contractions (%) 10 2 4 1 3 2 1 1 <0.05 <0.05
UES
Pressure (mmHg)† 63 3 71 6 ns
Relaxation time (second) 1.1 0.1 1.2 0. 1 ns
PHX
Contraction amplitude (mmHg) 38 15 39 16 ns
†Mean pressure at the high pressure zone of the sphincter. CIP, cervical inlet patch; DS, dry swallow; EB, esophageal body; ns, not
significant; PHX, pharynx; UES, upper esophageal sphincter; WS, wet swallow.
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the literature. Studies evaluating the prevalence of
CIP4–6 reported a large variance (<0.1–10%). This is
generally explained by the difficulty of endoscopic
detection. Because the heterotopic columnar mucosal
patch is usually located immediately below the upper
esophageal sphincter, it is easily overlooked by the
endoscopist if the withdrawal of the endoscope is not
careful enough.3 The primary purpose of the present
study was not to collect epidemiological data on the
prevalence of CIP in the population; accordingly, the
endoscopists were not called upon or instructed
to search for CIP during routine endoscopies. This
may contribute to the relatively low prevalence
rate observed in this study. Although the value of
new endoscopic techniques14 such as narrow band
imaging has not been tested yet for the detection of
CIP, to our knowledge, our unpublished initial expe-
rience with these endoscopic modalities indicate that
such contrast enhancement techniques can facilitate
the recognition of these lesions. Consequently these
techniques may help to provide more precise patient
selection for studies carried out in patients with CIP
and a better estimation of its prevalence. The histo-
logical structure of these mucosal patches is usually
oxyntic mucosa. There are only few reports available
on other glandular structures, such as intestinal
metaplasia.15–17 In our series, we found two cases with
SIM and one with low-grade dysplasia. Furthermore,
we observed other metaplastic tissues, such as PAM
and PDM, and superficial mucous glands in our
patients. The latter can be differentiated from car-
diac glands by its histomorphology, and it has not
been reported yet in this location by other authors.
Helicobacter pylori colonization in the heterotopic
mucosa is mainly considered as part of Helicobacter-
positive gastritis; however, its prevalence is different
in the conducted studies.18–20 We observed a relatively
low prevalence of Helicobacter-positive gastritis, and
none of the patients had Helicobacter colonization in
the heterotopic mucosa.
Regarding the clinical symptom spectrum, dysph-
agia and globus sensation are considered as major
symptoms associated with CIP.21–25 Others reported
significant respiratory symptoms as well.26,27 These
symptoms were commonly observed in our patients
but were less frequent than typical symptoms of
GERD, such as heartburn and acid regurgitation.
Similarly to the observation of Baudet et al.,21 such
symptoms were present at least weekly only in one-
fourth of our patients. Furthermore, the prevalence
Table 3 Results of simultaneous biliary reflux and double-channel esophageal pH-monitoring in patients with cervical inlet patch
(mean  SEM)
Patient group CIP (n = 65) Control (n = 25) P
pH – 20 cm above the LES
Number of pH < 4 episodes, 24 hours 14 3 4 1 <0.01
Upright 12 2 4 1 <0.01
Supine 1.3 0.6 0.1 0.1 <0.05
Postprandial 9 2 3 1 <0.01
>5 minutes, 24 hours 0.33 0.15 0.04 0.04 <0.05
Longest episode (minutes) 2.2 0.5 0.6 0.2 <0.01
Fraction time pH < 4, 24 hours (%) 0.5 0.1 0.1 0.1 <0.01
Upright (%) 0.8 0.2 0.3 0.1 <0.01
Supine (%) 0.12 0.06 0.01 0.01 <0.05
Postprandial (%) 1.3 0.3 0.5 0.2 <0.05
pH – 5 cm above the LES
Number of pH < 4 episodes, 24 hours 79 8 38 7 <0.01
Upright 65 7 32 6 <0.01
Supine 13.4 2.7 5.2 1.5 <0.01
Postprandial 46 5 22 5 <0.01
>5 minutes, 24 hours 2.33 0.57 0.60 0.26 <0.01
Longest episode (minutes) 13.8 4.6 4.2 1.0 <0.05
Fraction time pH < 4, 24 hours (%) 5.3 1.1 1.7 0.4 <0.01
Upright (%) 6.7 1.1 2.4 0.6 <0.01
Supine (%) 3.61 1.22 0.63 0.27 <0.02
Postprandial (%) 11.2 1.9 4.7 1.3 <0.01
DeMeester score 20.5 3.4 7.5 1.4 <0.01
Bile – 5 cm above the LES
Number of OD > 0.14 episodes, 24 hours 13 3 9 2 ns
Upright 10 2 7 2 ns
Supine 3.2 1.0 1.6 0.5 ns
Postprandial 5 1 3 1 ns
>5 minutes, 24 hours 2.70 0.54 1.40 0.29 <0.05
Longest episode (minutes) 58.2 18.1 18.8 4.3 <0.05
Fraction time OD > 0.14, 24 hours (%) 8.4 2.4 2.4 0.5 <0.02
Upright (%) 7.1 1.8 3.2 0.8 <0.05
Supine (%) 10.03 3.63 1.21 0.63 <0.02
Postprandial (%) 7.0 2.1 3.1 1.2 ns
CIP, cervical inlet patch; ns, not significant.
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of heartburn was also similar to their value (28%).
On the other hand, acid regurgitation was common;
hence, 50% of our patients had at least weekly occur-
ring symptoms typical of GERD. Although there are
data suggesting that the eradication of the CIP may
improve symptoms located at the level of the throat,
the pharynx, or the proximal esophagus,23 we are of
the opinion that further prospective studies with
longer follow-up periods are needed to rule out the
role of GERD or functional diseases in the genera-
tion of such symptoms.
The relationship between CIP and GERD or Bar-
rett’s esophagus is controversial in the literature. On
the basis of case reports – as adenocarcinoma may
develop from the heterotopic columnar mucosa –
some authors suspect the role of proximal gastro-
esophageal reflux in the pathogenesis of this lesion.
However, it should be noted that still less than 30
cases of proximal esophageal adenocarcinoma have
been reported in the literature.28 The similarities
between cytokeratin and mucin core protein expres-
sion in patients with CIP and Barrett’s esophagus
established by Lauwers et al.29 may support the pos-
sibility of ‘de novo’ development of heterotopic
columnar mucosal patches in the cervical esopha-
gus. The other theory considers CIP as a congenital
lesion – similarly to other heterotopic gastric mucosal
patches30 – and says that such patients have a higher
risk of developing GERD and Barrett’s esophagus.
Avidan et al.31 conducted an epidemiological study
and found an increased prevalence of GERD and
Barrett’s esophagus in patients with CIP. Although
our results may not end this debate, the prevalence of
GERD symptoms was higher compared with the data
obtained in the general population.32,33 Hiatal hernia
and endoscopic signs of GERD such as erosive
esophagitis were common, similar to the observation
of Baudet et al.21 Furthermore, the prevalence of
columnar metaplasia in the distal esophagus was also
high (13% SIM, 27% other). Esophageal function
analysis proved a significantly higher acidic and
biliary exposure of the esophagus in patients with
CIP compared with age-, sex-, and BMI-matched
controls. Manometric evaluation showed alterations
of the LES and esophageal body function, which may
predispose the patients to gastroesophageal reflux.
On the other hand, pathological proximal reflux was
not frequent enough to be a real cause of the devel-
opment of CIP. Only 38% of the cases had abnormal
acid exposure in the proximal esophagus, and the
majority of them only slightly exceeded the upper
limit of the internationally accepted normal values.
Although it is not known how much acidic (and/or
biliary) reflux would be necessary to induce metaplas-
tic transformation in the mucosa of the proximal
esophagus, patients with Barrett’s esophagus, where
a real metaplastic process is suspected, generally have
more severe acidic and biliary reflux.34,35 On the basis
of these findings, it would be interesting to examine
what other abnormalities may be related to this small
congenital lesion during the ontogenesis of the
esophagus that may consequently predispose these
patients to GERD.
The need for follow-up in patients with CIP is also
questionable. It is known that the lesion is generally
benign, as only a small number of malignant trans-
formations have been reported in the literature, and
to date, there has only been one patient with SIM and
high-grade dysplasia in the CIP.17 In contrast, we do
not know what degree of acid and/or bile exposure
may induce inflammation and cell proliferation at the
esophageal inlet and what factors can promote or
inhibit this process.
Besides these theories, an interesting new patho-
physiological hypothesis was published by Meining
and Bajbouj recently.2 According to their concept,
the variability in the macroscopic appearance of the
patches and in the onset of clinical symptoms may
not be explained by the embryological origin of this
lesion. They proposed that CIPs are erupted cysts
developing from occluded proximal esophageal
glands. Our results failed to provide a good support
for this new hypothesis, because our patients were
commonly free of symptoms related to the throat, the
pharynx, or the proximal esophagus. This may indi-
cate that if they ever had a cyst, it was also asymp-
tomatic. Despite these results, we agree that further
studies are needed to test this theory.
Acid secretion in the heterotopic glandular
mucosa is another interesting question. Although
some authors highlight on this,21,36 we found only
three cases (5%) in whom the proximal pH drop was
not preceded by a distal reflux episode. Taking into
account that pH probes can not always be positioned
accurately at the level of the heterotopic islands –
especially if they are smaller than 1 cm and the prox-
imal pH sensor is fixed at 15 cm above the distal
one – it is not surprising that we found such a low
prevalence of this. Furthermore, the acid produc-
tion of these patches compared with the volume of
saliva swallowed is probably not enough to produce
a significant drop in the pH (to pH < 4).
Regarding gastrointestinal comorbidities, the
observed disorders were all infrequent and probably
accidental.
CONCLUSIONS
The detailed evaluation of the esophageal morphol-
ogy and function in subjects with CIP showed a
high prevalence of GERD and Barrett’s esophagus.
Further studies are needed to evaluate whether com-
bined acidic and biliary reflux is able to promote
similar histomorphological changes in the CIP, as it is
shown distally in patients with Barrett’s esophagus.
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